• Celebrate the holiday season with AcceGen’s highest discounts of the year. Merry Christmas and Happy New Year!

    Learn More
Tumor Cell Lines

BT-549

  • BSL

    1

  • 145
The BT-549 line was isolated in 1978 by W.G. Coutinho and E.Y. Lasfargues. Source tissue consisted of a papillary, invasive ductal tumor which had metastasized to 3 of 7 regional lymph nodes.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options

The BT-549 cell line, also known as HTB-122, originates from an invasive ductal tumor in the breast of a 72-year-old female cancer patient with extensive lymph node metastasis. Isolated in 1978, these epithelial cells maintain typical breast and mammary gland tissue characteristics. Notably, BT-549BT-549 cells exhibit aneuploidy with a modal chromosome count of 78, ranging from 73 to 80, and aberrations in the X chromosomes. Chromosomes N10 and N13 are underrepresented, while N2, N12, N17, and N8 deviate from normal copy numbers. Chromosomes N5 and N18 typically display increased copies. Additionally, BT-549 cells carry four marker chromosomes: iso(13q), 10q+, del(x)(q22:), and del(11)(p11:). These cells have a doubling time of around 3.7 days.

 

Why choose BT-549 from AcceGen?

The BT-549 cell line from AcceGen offers high viability and quality, having been cryopreserved using advanced techniques. These cells are maintained under optimal conditions, ensuring their sterility as they are rigorously screened for the absence of bacteria, fungi, and mycoplasma, meeting stringent quality control standards.

Product Code

BT 549; BT.549; BT549

Species

Human

Cat.No

ABC-TC0087

Product Category Tumor Cell Lines
Size/Quantity

1 vial

Cell Type

Epithelial

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Breast

Disease

Ductal Cancer

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Human Breast Cancer Cell Lines

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

View More
View Product Image

Application

  • FOR RESEARCH USE ONLY

  • The BT-549 cell line has emerged as a valuable asset in biological science, primarily within the realms of cancer research and 3D cell culture applications. Its significance lies in its relevance to ductal carcinoma, particularly in gaining insights into its mechanisms and potential therapeutic targets. As a pivotal component of cancer research, BT-549 cells enable a deeper understanding of carcinoma development and the exploration of innovative treatment strategies. Moreover, their applicability in 3D cell culture makes them an ideal tool for simulating the intricate tumor microenvironment, facilitating the study of drug responses and tumor progression in a more physiologically relevant context.

Inquiring BT-549

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

  • Breast (73)
  • Breast Cancer (68)
  • Epithelial (292)
  • Human (1729)
AcceGen Scroll Top Button